Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High Thoracic Epidural Reduces Risks of Increased Left Ventricular Mass Index and Coronary Vascular Disease During Aortic Valve Replacement Alone or in Addition to Coronary Artery Bypass Graft Surgery

NCT03719248 is registered in ClinicalTrials.gov with Ahmed Said Elgebaly,MD as lead sponsor.

NCT NCT03719248
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03719248 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High Thoracic Epidural Reduces Risks of Increased Left Ventricular Mass Index and Coronary Vascular Disease During Aortic Valve Replacement Alone or in Addition to Coronary Artery Bypass Graft Surgery
Lead sponsor
Ahmed Said Elgebaly,MD
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2017
Completion date
January 1, 2018
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischemia coronary artery origin